Two Sigma Investments’s iShares China Large-Cap ETF FXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,000
Closed -$462K 3466
2020
Q3
$462K Sell
11,000
-48,000
-81% -$2.06M ﹤0.01% 2310
2020
Q2
$2.34M Sell
59,000
-99,300
-63% -$3.87M 0.01% 1017
2020
Q1
$5.94M Sell
158,300
-90,800
-36% -$3.7M 0.05% 430
2019
Q4
$10.9M Buy
249,100
+32,900
+15% +$1.37M 0.03% 584
2019
Q3
$8.61M Buy
216,200
+33,200
+18% +$1.35M 0.03% 603
2019
Q2
$7.83M Sell
183,000
-22,700
-11% -$970K 0.03% 700
2019
Q1
$9.11M Sell
205,700
-18,000
-8% -$768K 0.03% 692
2018
Q4
$8.74M Buy
223,700
+109,900
+97% +$4.44M 0.03% 587
2018
Q3
$4.87M Sell
113,800
-153,300
-57% -$6.49M 0.01% 959
2018
Q2
$11.5M Buy
+267,100
New +$12.5M 0.03% 607
2017
Q4
Sell
-11,400
Closed -$502K 3209
2017
Q3
$502K Buy
+11,400
New +$489K ﹤0.01% 2147
2016
Q4
Sell
-20,900
Closed -$794K 3248
2016
Q3
$794K Buy
20,900
+13,500
+182% +$495K ﹤0.01% 2138
2016
Q2
$253K Buy
+7,400
New +$246K ﹤0.01% 2648

Other funds holding FXI

Two Sigma Investments's FXI Position: Q1 2026 in Review

Two Sigma Investments sold out of iShares China Large-Cap ETF (FXI) in Q1 2026, closing a stake of 834,400 shares — an estimated $31.9M sold.

Two Sigma Investments first reported a position in FXI in Q3 2013 and held it in 23 quarters. The position peaked at $66.9M in Q2 2025. 342 funds tracked by Wall St. Rank hold FXI as of Q1 2026.

  • Two Sigma Investments reported no remaining iShares China Large-Cap ETF position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 834,400 iShares China Large-Cap ETF shares in Q1 2026, an estimated $31.9M.
  • Two Sigma Investments first reported a position in iShares China Large-Cap ETF in Q3 2013 and held it in 23 quarters.
  • Two Sigma Investments's iShares China Large-Cap ETF position peaked at $66.9M in Q2 2025.
  • 342 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.